Sara Gagno

Scopus Author ID ResearcherID ORCID

Publication Activity (10 Years)

Years Active: 2020-2023
Publications (10 Years): 4

Top Topics

Prognostic Factors

Chronic Myeloid Leukemia

Ejection Fraction

Top Venues

Pharmacogenomics

Daru : journal of Faculty of Pharmacy, Tehran University of Medical Sciences

British journal of clinical pharmacology

This page only lists publications with an associated author ORCID identifier.

Publications

Sara Gagno, Chiara Dalle Fratte, Bianca Posocco, Angela Buonadonna, Arianna Fumagalli, Michela Guardascione, Giuseppe Toffoli, Erika Cecchin
Therapeutic drug monitoring and pharmacogenetics to tune imatinib exposure in gastrointestinal stromal tumor patients: hurdles and perspectives for clinical implementation. Pharmacogenomics (2023)
Sara Gagno, Angela Buonadonna, Chiara Dalle Fratte, Michela Guardascione, Martina Zanchetta, Bianca Posocco, Marco Orleni, Giovanni Canil, Rossana Roncato, Erika Cecchin, Giuseppe Toffoli
The use of therapeutic drug monitoring to highlight an over-looked drug-drug interaction leading to imatinib treatment failure. Daru : journal of Faculty of Pharmacy, Tehran University of Medical Sciences (2023)
Chiara Dalle Fratte, Sara Gagno, Rossana Roncato, Jerry Polesel, Martina Zanchetta, Mauro Buzzo, Bianca Posocco, Elena De Mattia, Rachele Borsatti, Fabio Puglisi, Luisa Foltran, Michela Guardascione, Angela Buonadonna, Erika Cecchin, Giuseppe Toffoli
CYP2D6 and CYP2C8 pharmacogenetics and pharmacological interactions to predict imatinib plasmatic exposure in GIST patients. British journal of clinical pharmacology (2022)
Sara Gagno, Michele Bartoletti, Chiara Romualdi, Elena Poletto, Simona Scalone, Roberto Sorio, Martina Zanchetta, Elena De Mattia, Rossana Roncato, Erika Cecchin, Giorgio Giorda, Giuseppe Toffoli
Pharmacogenetic score predicts overall survival, progression-free survival and platinum sensitivity in ovarian cancer. Pharmacogenomics 21 (14) (2020)